How the COVID-19 Pandemic Impacts Lives of Life Scientists

The coronavirus has caused a pervading disaster worldwide. In fact, the COVID-19 pandemic is not a crisis but a catastrophe, facing the dramatic global increase in morbidity and mortality rates, and the SARS-CoV-2 outbreak has disrupted virtually everyone's daily life.

While the pandemic is having massive economic and environmental impacts, COVID-19 has also posed an unprecedented challenge to the scientific community. Thus, basic research and clinical investigations are being performed “at full speed” to explore the biology and evolution of SARS-CoV-2, evaluate the pathogenesis and epidemiology of the disease, elucidate host responses and host genetics, mitigate or prevent complications, and develop and test potential therapies. Until April 2020, more than 1,000 clinical studies worldwide pertaining COVID-19 were recorded.[1] As a result of national and international activities and joint ventures, several anti-COVID-19 vaccines have been developed that have been or are being approved by the respective regulatory authorities and now available for mass-scale immunization of the population.

Apart from these activities and achievements, throughout the pandemic, many individual scientists have experienced a pressure to understand, mitigate, and cure COVID-19 or, at least, to provide a personal contribution in their field of expertise.[2] Interestingly, Korbel and Stegle reported in a survey assessing the effects of the COVID-19 pandemic on life scientists that approximately 20% of the respondents indicated that they shifted their research focus with the aim to combat COVID-19.[3]

Publication History

Received: 18 December 2020

Accepted: 19 December 2020

Article published online:
15 February 2021

• References

• 1 Statista. Accessed December 23, 2020 at: https://de.statista.com/infografik/21489/globale-anzahl-der-taeglich-neu-gemeldeten-klinischen-studien-zum-coronavirus/2020
• 2 Scharf RE. Productivity of young experts in hemostasis and thrombosis before and during the SARS-CoV-2 pandemic - a special issue. Hamostaseologie 2020; 40 (03) 255-256
• 3 Korbel JO, Stegle O. Effects of the COVID-19 pandemic on life scientists. Genome Biol 2020; 21 (01) 113
• 4 National Library of Medicine. PubMed. Accessed December 23, 2020 at: www.nlm.nih.gov 2020
• 5 Eisen MB, Akhmanova A, Behrens TE, Weigel D. Publishing in the time of COVID-19. eLife 2020; 9: e57162
• 6 Termini CM, Traver D. Impact of COVID-19 on early career scientists: an optimistic guide for the future. BMC Biol 2020; 18 (01) 95
• 7 Eisen MB, Akhmanova A, Behrens TE, Harper DM, Weigel D, Zaidi M. Implementing a “publish, then review” model of publishing. eLife 2020; 9: e64910
• 8 Ramanan M, Stolz A, Rooplalsingh R, Billot L, Myburgh J, Venkatesh B. An evaluation of the quality and impact of the global research response to the COVID-19 pandemic. Med J Aust 2020; 213 (08) 380-380.e1
• 9 Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Cardiovascular disease, drug therapy, and mortality in Covid-19. N Engl J Med 2020; 382 (25) e102
• 10 Mehra MR, Desai SS, Ruschitzka F, Patel AN. RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet 2020; S0140-6736(20)31180-6 DOI: 10.1016/S0140-6736(20)31180-6.
• 11 Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Retraction: cardiovascular disease, drug therapy, and mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621. N Engl J Med 2020; 382 (26) 2582
• 12 Mehra MR, Ruschitzka F, Patel AN. Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet 2020; 395 (10240): 1820
• 13 The Editors Of The Lancet Group. Learning from a retraction. Lancet 2020; 396 (10257): 1056
• 14 Myers KR, Tham WY, Yin Y. et al. Unequal effects of the COVID-19 pandemic on scientists. Nat Hum Behav 2020; 4 (09) 880-883
• 15 Rijs C, Fenter F. The academic response to COVID-19. Front Public Health 2020; 8: 621563
• 16 Scharf RE. Implications and impact of the COVID-19 pandemic on life scientists. 2020 (article is submitted and under review)
• 17 Scharf RE. Enormer Anstieg der Produktivität. Auswirkungen der COVID-19-Pandemie auf den Alltag von Lebenswissenschaftlern. Forschung & Lehre, DHV 2021; 28 (02) 132-133
• 18 Subramanya SH, Lama B, Acharya KP. Impact of COVID-19 pandemic on the scientific community. Qatar Med J 2020; 2020 (01) 21
• 19 Su L. My lab is closed to me because of the coronavirus. Here's how I'm planning to stay productive. Nature 2020; (e-pub ahead of print) DOI: 10.1038/d41586-020-00986-6.
• 20 Campos MM. The impact of COVID-19 on women in science - reflections on the WISCovid19 conference. 2020 . Accessed December 23, 2020 at: https://ellipse.prbb.org/the-impact-of-covid-19-on-women-in-science-reflections-on-the-wiscovid19-conference/
• 21 Alba Network. The impact of COVID-19 on women and minorities in science. 2020 , Accessed December 23, 2020 at: http://www.alba.network/impact-covid-19-women-and-minorities-science
• 22 Scharf RE. About mentees and mentors: what kind of advanced training should young scientists receive? - A personal reflection. Hamostaseologie 2020; 40 (03) 379-381
• 23 Alberio L. GTH 2021: simply online … worth experiencing. Hamostaseologie 2020; 40: 558-559
• 24 Alberio L. GTH 2021: ACROSS BORDERS. Hamostaseologie 2021; 41: 5-6